World’s Top-Selling Drug Going Off Patent Means Big Bucks for Middlemen
MarketsHeard on the StreetAs AbbVie’s Humira faces copycat biologics, the biggest beneficiaries will be the middlemen negotiating and dispensing the ...
Monday, June 1, 2026
Tag: Generic/Biosimilar Drugs
Viatris Executive Charged in Insider-Trading Scheme Allegedly Netting Millions
MarketsFinancial RegulationProsecutors and regulators say healthcare company executive tipped friend to company’s drug approval
EDITOR'S PICK
EP NEWSROOM
© 2025 Edinburg Post or its affiliated companies.